Eric Tai-Lee Wong, MD

Eric Tai-Lee Wong, MD

Neuro-Oncologist

Eric T. Wong, MD, an authority on advanced treatments for glioblastoma, joined the Lifespan Cancer Institute to direct the medical neuro-oncology service. He brings extensive knowledge and research experience that focuses on device and drug therapies for primary malignant brain tumors, imaging of neurologic malignancies, and management of leptomeningeal metastases in the central nervous system. In the past two decades, his work has led to the development of innovative cancer treatment technologies, and simultaneously transformed the management of brain cancer by oncologists.

Dr. Wong earned a bachelor of science degree in electrical engineering from the University of Pennsylvania and a doctor of medicine degree from Rutgers Robert Wood Johnson Medical School. He pursued an internship in internal medicine at the Rutgers New Jersey Medical School, followed by a residency in neurology at Barnes Jewish Hospital, Washington University School of Medicine as well as fellowships in neuro-oncology at Memorial-Sloan Kettering Cancer Center and the University of Texas MD Anderson Cancer Center.

Prior to joining Lifespan, Dr. Wong was the director of the neuro-oncology unit, and co-director of the Brain Tumor Center, both located at Beth Israel Deaconess Medical Center in Boston. He also served on the neuro-oncology protocol committee at Dana Farber Cancer Institute. Over the course of nearly 25 years, he investigated the mechanisms of action and applications of the NovoTTF-100A device that emits Tumor Treating Fields, or alternating electric fields, to treat brain cancer, while he received funding from the National Cancer Institute, foundations, and leading device and pharmaceutical companies.

His seminal work helped the initial approval of the therapeutic device by the United States FDA in 2011 and the publication of the first textbook on the subject, Alternating Electric Fields Therapy in Oncology: A Practical Guide to Clinical Applications of Tumor Treating Fields, in 2016. In 2021, he was honored as a distinguished lecturer in the Engineering in Medicine and Biology Society of the Institute of Electrical and Electronic Engineers. He was also presented with the Oncologist of the Year award by the Massachusetts Society of Clinical Oncologists.

Throughout his career, Dr. Wong has been a lead author and contributing writer to numerous professional journals, scientific communications, and medical media. Dr. Wong has served as an editorial reviewer and ad hoc reviewer for Annals of Neurology, International Journal of Cancer, Journal of Clinical Oncology, Journal of Neuro-Oncology, Lancet Oncology, Medical Physics, Neurology, Neuro-Oncology, Translational Oncology, and other publications. He is an active member of many oncology and scientific organizations, including American Academy of Neurology, American Association for Cancer Research, American Neurological Association and American Society of Clinical Oncology.

He participated as a study section reviewer for the National Cancer Institute and the American Association for Cancer Research. He also served as a clinical advisor for National Government Services, a contractor for the Center for Medicare and Medicaid Services, and the national Blue Cross Blue Shield Association.

Dr. Wong takes particular pride in training the next generation of neuro-oncologists, some of whom are leaders in academic and medical institutions carrying out the tripartite mission of patient care, research, and education. 

Dr. Wong's patients have followed him from Boston to Lifespan

Locations

Primary

Lifespan Cancer Institute, Rhode Island Hospital
Ambulatory Patient Center (APC Building) (directions)
110 Lockwood St.
Providence, RI 02903

Education

  • Medical School:  Rutgers Robert Wood Johnson Medical School
  • Fellowship:  MD Anderson Cancer Center
  • Fellowship:  Memorial Sloan-Kettering Cancer Center
  • Internship:  University of Medicine and Dentistry of New Jersey
  • Residency:  Barnes-Jewish Hospital